Handelsbanken Fonder’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.19M	Buy	+280,000	New	+$3.19M	0.01%	515
2022 Q1	–	Sell	-7,600	Closed	-$220K	–	1718
2021 Q4	$220K	Buy	+7,600	New	+$220K	﹤0.01%	1685